Search

Amanda Marie Haney

Examiner (ID: 15654, Phone: (571)272-8668 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1682
Total Applications
1025
Issued Applications
286
Pending Applications
134
Abandoned Applications
624

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20093719 [patent_doc_number] => 20250223655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY [patent_app_type] => utility [patent_app_number] => 19/088496 [patent_app_country] => US [patent_app_date] => 2025-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088496 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/088496
METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY Mar 23, 2025 Pending
Array ( [id] => 20093692 [patent_doc_number] => 20250223628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY [patent_app_type] => utility [patent_app_number] => 19/012392 [patent_app_country] => US [patent_app_date] => 2025-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012392 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/012392
METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY Jan 6, 2025 Pending
Array ( [id] => 19449303 [patent_doc_number] => 20240309433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHOD FOR EVALUATING TEA PLANT (+)-CATECHIN CONTENT [patent_app_type] => utility [patent_app_number] => 18/662886 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662886 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662886
Method for evaluating tea plant (+)-catechin content May 12, 2024 Issued
Array ( [id] => 19449332 [patent_doc_number] => 20240309462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER [patent_app_type] => utility [patent_app_number] => 18/657581 [patent_app_country] => US [patent_app_date] => 2024-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19527 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657581 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/657581
METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER May 6, 2024 Pending
Array ( [id] => 19218261 [patent_doc_number] => 20240182965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => System and Method for Sequencing [patent_app_type] => utility [patent_app_number] => 18/437474 [patent_app_country] => US [patent_app_date] => 2024-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63852 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437474 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/437474
System and Method for Sequencing Feb 8, 2024 Pending
Array ( [id] => 19528629 [patent_doc_number] => 20240352531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METHOD FOR DETECTING CD19 EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/432678 [patent_app_country] => US [patent_app_date] => 2024-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18432678 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/432678
METHOD FOR DETECTING CD19 EXPRESSION Feb 4, 2024 Pending
Array ( [id] => 19513330 [patent_doc_number] => 20240345016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => IMPEDANCE-BASED LIQUID BIOPSY SYSTEM AND METHOD FOR DETECTING AND SCREENING CANCER [patent_app_type] => utility [patent_app_number] => 18/683145 [patent_app_country] => US [patent_app_date] => 2024-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683145 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/683145
IMPEDANCE-BASED LIQUID BIOPSY SYSTEM AND METHOD FOR DETECTING AND SCREENING CANCER Jan 28, 2024 Pending
Array ( [id] => 19556901 [patent_doc_number] => 20240368693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 18/422276 [patent_app_country] => US [patent_app_date] => 2024-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/422276
METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT Jan 24, 2024 Pending
Array ( [id] => 20173261 [patent_doc_number] => 12391995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-19 [patent_title] => Epigenetic markers and related methods and means for the detection and management of certain cancers [patent_app_type] => utility [patent_app_number] => 18/418913 [patent_app_country] => US [patent_app_date] => 2024-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 21 [patent_no_of_words] => 44300 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418913 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/418913
Epigenetic markers and related methods and means for the detection and management of certain cancers Jan 21, 2024 Issued
Array ( [id] => 19281990 [patent_doc_number] => 20240218464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => DNA BARCODE FOR SCREENING FLOCCULARIA LUTEOVIRENS WITH HIGH TOTAL FAT CONTENT [patent_app_type] => utility [patent_app_number] => 18/418417 [patent_app_country] => US [patent_app_date] => 2024-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418417 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/418417
DNA BARCODE FOR SCREENING FLOCCULARIA LUTEOVIRENS WITH HIGH TOTAL FAT CONTENT Jan 21, 2024 Pending
Array ( [id] => 19404067 [patent_doc_number] => 20240287578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION [patent_app_type] => utility [patent_app_number] => 18/413996 [patent_app_country] => US [patent_app_date] => 2024-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413996 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/413996
CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION Jan 15, 2024 Pending
Array ( [id] => 19710528 [patent_doc_number] => 20250020670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS [patent_app_type] => utility [patent_app_number] => 18/412046 [patent_app_country] => US [patent_app_date] => 2024-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18412046 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/412046
PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS Jan 11, 2024 Abandoned
Array ( [id] => 19631540 [patent_doc_number] => 20240409989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA [patent_app_type] => utility [patent_app_number] => 18/404829 [patent_app_country] => US [patent_app_date] => 2024-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404829 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/404829
METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA Jan 3, 2024 Pending
Array ( [id] => 19332883 [patent_doc_number] => 20240247313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF OPIOID-RELATED DISORDERS [patent_app_type] => utility [patent_app_number] => 18/394729 [patent_app_country] => US [patent_app_date] => 2023-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394729 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/394729
Serotonin transporter gene and treatment of opioid-related disorders Dec 21, 2023 Issued
Array ( [id] => 20329985 [patent_doc_number] => 12460252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => MLH1 methylation assay [patent_app_type] => utility [patent_app_number] => 18/535773 [patent_app_country] => US [patent_app_date] => 2023-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 9235 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 480 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535773 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/535773
MLH1 methylation assay Dec 10, 2023 Issued
Array ( [id] => 19345598 [patent_doc_number] => 20240254561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/527076 [patent_app_country] => US [patent_app_date] => 2023-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527076 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/527076
METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS Nov 30, 2023 Pending
Array ( [id] => 19404919 [patent_doc_number] => 20240288430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER [patent_app_type] => utility [patent_app_number] => 18/513107 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513107 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/513107
THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER Nov 16, 2023 Abandoned
Array ( [id] => 19188182 [patent_doc_number] => 20240167095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS [patent_app_type] => utility [patent_app_number] => 18/511249 [patent_app_country] => US [patent_app_date] => 2023-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/511249
METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS Nov 15, 2023 Pending
Array ( [id] => 19083447 [patent_doc_number] => 20240110248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA [patent_app_type] => utility [patent_app_number] => 18/379355 [patent_app_country] => US [patent_app_date] => 2023-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73007 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/379355
Extract from a body fluid comprising a micro RNA Oct 11, 2023 Issued
Array ( [id] => 20433441 [patent_doc_number] => 12503733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-23 [patent_title] => Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease [patent_app_type] => utility [patent_app_number] => 18/240789 [patent_app_country] => US [patent_app_date] => 2023-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 47277 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240789 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/240789
Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease Aug 30, 2023 Issued
Menu